Arcellx, CAR T Therapy, CART DDBCMA, soo -dhoweeyaha kiimikada chimeric, Kite Pharma, Meelo badan
KITE IYO ARCELLX HESHIISKA DHAGAN EE LAGU HORUMARINTAY IYO KA WADA-GAANACSIINTA GUDAHA CLINICAL CART-DDBCMA MYELOMA BADAN
SANTA MONICA, Calif. & REDWOOD CITY, Calif.--(GANACSIGA) -- Kite, oo ah Shirkadda Gilecaad (NASDAQ: GILD), iyo Arcellx, Inc. (NASDAQ: ACLX), ayaa maanta ku dhawaaqay xidhitaanka shirkadihii hore. lagu dhawaaqay istaraatiijiyada caalamiga ah..
Ball, Brexucabtagene autoleucel, Kite Pharma, Tecartus, ZUMA-3
Brexucabtagene autoleucel waxa u ansixisay FDA dib u soo noqoshada ama dib u soo noqoshada unugyada B-cell ee leukemia ba'an
Oktoobar 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) waxaa u ansixiyay Maamulka Cuntada iyo Dawooyinka ee bukaanada qaangaarka ah ee soo noqnoqday ama dib u celinaya unugyada B-unugyada limfoblastic leukemia (ALL). Gudaha
axicabtagene ciloleucel, CAR - T Daaweynta unugyada, CD19, sinjiyeynta follicular, Kite Pharma, lymphoma follicular refractory, lymphoma follicular soo noqnoqday, Yescarta
FDA waxay siisay axicabtagene ciloleucel oggolaansho degdeg ah oo loogu talagalay dib -u -noqoshada ama lymfoma follicular refractory.
Agoosto 2021: FDA waxay siisay axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) oggolaanshaha degdega ah ee bukaanada qaangaarka ah ee soo noqnoqda ama follicular lymphoma (FL) ka dib laba ama in ka badan oo daawaynta habaysan. hees